Page last updated: 2024-08-21

adamantane and Bone Loss, Osteoclastic

adamantane has been researched along with Bone Loss, Osteoclastic in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Emori, T; Fujii, Y; Hanaoka, K; Nakamura, Y; Nakano, M; Sugahara, S; Suzuki, T; Takahashi, J; Takeshita, N	1
Huang, YX; Tao, JG; Zhao, HX	1
Eom, YS; Gwon, AR; Kim, BJ; Kim, JY; Kim, KW; Kim, YS; Kwak, KM; Lee, K; Lee, S; Park, IB; Yu, SH	1
Bunck, MC; Diamant, M; Eekhoff, EM; Foley, JE; Heine, RJ; Nijpels, G; Poelma, M; Schweizer, A	1

Trials

1 trial(s) available for adamantane and Bone Loss, Osteoclastic

Article	Year
Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients. Journal of diabetes, 2012, Volume: 4, Issue:2 Topics: Adamantane; Aged; Alkaline Phosphatase; Biomarkers; Blood Glucose; Bone and Bones; Bone Resorption; Calcium; Collagen Type I; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glucagon-Like Peptide 1; Homeostasis; Humans; Insulin; Male; Middle Aged; Netherlands; Nitriles; Peptides; Phosphates; Postprandial Period; Pyrrolidines; Time Factors; Treatment Outcome; Vildagliptin	2012

Article

Year

Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients.

Journal of diabetes, 2012, Volume: 4, Issue:2

Topics: Adamantane; Aged; Alkaline Phosphatase; Biomarkers; Blood Glucose; Bone and Bones; Bone Resorption; Calcium; Collagen Type I; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glucagon-Like Peptide 1; Homeostasis; Humans; Insulin; Male; Middle Aged; Netherlands; Nitriles; Peptides; Phosphates; Postprandial Period; Pyrrolidines; Time Factors; Treatment Outcome; Vildagliptin

2012

Other Studies

3 other study(ies) available for adamantane and Bone Loss, Osteoclastic

Article	Year
Peficitinib improves bone fragility by recovering bone turnover imbalance in arthritic mice. Journal of pharmacological sciences, 2022, Volume: 148, Issue:1 Topics: Adamantane; Animals; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Disease Models, Animal; Janus Kinase Inhibitors; Male; Mice, Inbred DBA; Niacinamide; Osteoblasts; Osteoporosis; RANK Ligand	2022
ST1926 Attenuates Steroid-Induced Osteoporosis in Rats by Inhibiting Inflammation Response. Journal of cellular biochemistry, 2017, Volume: 118, Issue:8 Topics: Adamantane; Alkaline Phosphatase; Animals; beta Catenin; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Proteins; Bone Resorption; Cinnamates; Gene Expression Regulation; Male; Methylprednisolone; Methylprednisolone Acetate; NF-kappa B; Osteoblasts; Osteoclasts; Osteonecrosis; Osteoprotegerin; Rats; Rats, Wistar; Signal Transduction; Wnt3A Protein	2017
Protective Effects of Vildagliptin against Pioglitazone-Induced Bone Loss in Type 2 Diabetic Rats. PloS one, 2016, Volume: 11, Issue:12 Topics: Adamantane; Animals; Biomarkers; Bone Density; Bone Resorption; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Male; Nitriles; Pioglitazone; Pyrrolidines; Rats; Rats, Zucker; Tartrate-Resistant Acid Phosphatase; Thiazolidinediones; Vildagliptin	2016